Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lancet Infect Dis. 2011 Aug;11(8):622-32. doi: 10.1016/S1473-3099(11)70147-5.
The changing epidemiology of yellow fever and continued reports of rare but serious adverse events associated with yellow fever vaccine have drawn attention to the need to revisit criteria for the designation of areas with risk for yellow fever virus activity, and to revise the vaccine recommendations for international travel. WHO convened a working group of international experts to review factors important for the transmission of yellow fever virus and country-specific yellow fever information, to establish criteria for additions to or removal from the list of countries with risk for yellow fever virus transmission, to update yellow fever risk maps, and to revise the recommendations for vaccination for international travel. This report details the recommendations made by the working group about criteria for the designation of risk and specific changes to the classification of areas with risk for transmission of yellow fever virus.
黄热病的流行情况正在发生变化,且有关黄热病疫苗罕见但严重不良反应的报告仍时有出现,这引起了人们对重新审视确定黄热病病毒活动风险地区的标准以及修订国际旅行疫苗接种建议的重视。世卫组织召集了一个国际专家组工作组,以审查与黄热病病毒传播有关的重要因素和各国的黄热病信息,确定在黄热病病毒传播风险国家名单中增加或删除国家的标准,更新黄热病风险图,并修订国际旅行疫苗接种建议。本报告详细介绍了工作组关于确定风险标准的建议以及黄热病病毒传播风险地区分类的具体变化。